Claggett, Brian

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Solomon, S. D., McMurray, J. J. V., Claggett, B., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., et al. (2022) · New England Journal of Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 2,884

Spironolactone for heart failure with preserved ejection fraction

Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine

Heart Failure Treatment and ManagementHormonal Regulation and Hypertension

Cited by 2,809

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., et al. (2019) · New England Journal of Medicine

Heart Failure Treatment and ManagementRenin-Angiotensin System Studies

Cited by 2,430

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., et al. (2015) · New England Journal of Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,409

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

Vaduganathan, M., Docherty, K. F., Claggett, B. L., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., et al. (2022) · The Lancet

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 996

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Solomon, S. D., McMurray, J. J. V., Vaduganathan, M., Claggett, B., Jhund, P. S., Desai, A. S., Henderson, A. D., Lam, C. S. P., Pitt, B., Senni, M., et al. (2024) · New England Journal of Medicine

Heart Failure Treatment and ManagementHormonal Regulation and Hypertension

Cited by 893

Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis

Seidelmann, S. B., Claggett, B., Cheng, S., Henglin, M., Shah, A., Steffen, L. M., Folsom, A. R., Rimm, E. B., Willett, W. C., & Solomon, S. D. (2018) · The Lancet Public Health

Nutritional Studies and DietDiet and metabolism studies

Cited by 776

Sex Differences in Blood Pressure Trajectories Over the Life Course

Ji, H., Kim, A., Ebinger, J. E., Niiranen, T. J., Claggett, B. L., Bairey Merz, C. N., & Cheng, S. (2020) · JAMA Cardiology

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 556

Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone

Shah, A. M., Claggett, B., Sweitzer, N. K., Shah, S. J., Anand, I. S., Liu, L., Pitt, B., Pfeffer, M. A., & Solomon, S. D. (2015) · Circulation

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 478

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

Neuen, B. L., Heerspink, H. J. L., Vart, P., Claggett, B. L., Fletcher, R. A., Arnott, C., de Oliveira Costa, J., Falster, M. O., Pearson, S.-A., Mahaffey, K. W., et al. (2024) · Circulation

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 358

Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic

Bhatt, A. S., Moscone, A., McElrath, E. E., Varshney, A. S., Claggett, B. L., Bhatt, D. L., Januzzi, J. L., Butler, J., Adler, D. S., Solomon, S. D., et al. (2020) · Journal of the American College of Cardiology

COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies

Cited by 357

Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities–Sleep Heart Health Study

Roca, G. Q., Redline, S., Claggett, B., Bello, N., Ballantyne, C. M., Solomon, S. D., & Shah, A. M. (2015) · Circulation

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 182

Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction

Bello, N. A., Claggett, B., Desai, A. S., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Pfeffer, M. A., & Solomon, S. D. (2014) · Circulation: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 147

Comparison of time-to-first event and recurrent-event methods in randomized clinical trials

Claggett, B., Pocock, S., Wei, L. J., Pfeffer, M. A., McMurray, J. J. V., & Solomon, S. D. (2018) · Circulation

Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference

Cited by 118

Distinct neural representations of placebo and nocebo effects

Freeman, S., Yu, R., Egorova, N., Chen, X., Kirsch, I., Claggett, B., Kaptchuk, T. J., Gollub, R. L., & Kong, J. (2015) · NeuroImage

Pain Management and Placebo EffectPain Mechanisms and Treatments

Cited by 116

Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

Lewis, E. F., Kim, H.-Y., Claggett, B., Spertus, J., Heitner, J. F., Assmann, S. F., Kenwood, C. T., Solomon, S. D., Desai, A. S., Fang, J. C., et al. (2016) · Circulation: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 114

Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk

Seidelmann, S. B., Feofanova, E., Yu, B., Franceschini, N., Claggett, B., Kuokkanen, M., Puolijoki, H., Ebeling, T., Perola, M., Salomaa, V., et al. (2018) · Journal of the American College of Cardiology

Genetic Associations and EpidemiologyNutrition, Genetics, and Disease

Cited by 97

Statistical workflow for feature selection in human metabolomics data

Antonelli, J., Claggett, B. L., Henglin, M., Kim, A., Ovsak, G., Kim, N., Deng, K., Rao, K., Tyagi, O., Watrous, J. D., et al. (2019) · Metabolites

Metabolomics and Mass Spectrometry StudiesGene expression and cancer classification

Cited by 88

Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction

Kosiborod, M. N., Bhatt, A. S., Claggett, B. L., Vaduganathan, M., Kulac, I. J., Lam, C. S. P., Hernandez, A. F., Martinez, F. A., Inzucchi, S. E., Shah, S. J., et al. (2023) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 86

Left Ventricular Ejection Time is an Independent Predictor of Incident Heart Failure in a Community-Based Cohort

Biering-Sørensen, T., Querejeta Roca, G., Hegde, S. M., Shah, A. M., Claggett, B., Mosley, T. H., Butler, K. R., & Solomon, S. D. (2018) · European Journal of Heart Failure

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 76

Electrocardiographic deep learning for predicting post-procedural mortality: a model development and validation study

Ouyang, D., Theurer, J., Stein, N. R., Hughes, J. W., Elias, P., He, B., Yuan, N., Duffy, G., Sandhu, R. K., Ebinger, J., et al. (2024) · The Lancet Digital Health

ECG Monitoring and AnalysisCardiac, Anesthesia and Surgical Outcomes

Cited by 64

Widening racial differences in risks for coronary heart disease.

Nadruz, W., Claggett, B., Henglin, M., Shah, A. M., Skali, H., Rosamond, W. D., Folsom, A. R., Solomon, S. D., & Cheng, S. (2018) · Circulation

Health disparities and outcomesCardiovascular Health and Risk Factors

Cited by 43

Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF

Yang, M., Henderson, A. D., Talebi, A., Atherton, J. J., Chiang, C.-E., Chopra, V., Comin-Colet, J., Kosiborod, M. N., Kerr Saraiva, J. F., Claggett, B. L., et al. (2025) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHormonal Regulation and Hypertension

Cited by 41

Large-scale proteomics identifies novel biomarkers and circulating risk factors for aortic stenosis

Shelbaya, K., Arthur, V., Yang, Y., Dorbala, P., Buckley, L., Claggett, B., Skali, H., Dufresne, L., Yang, T.-Y., Engert, J. C., et al. (2024) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsAdvanced Proteomics Techniques and Applications

Cited by 41